http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2256460-C2
Outgoing Links
| Predicate | Object |
|---|---|
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-375 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P11-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-245 |
| filingDate | 2003-09-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2005-07-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fa89d8faa3d7518928d23de6d625b17b http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2ef9cbe0d72cf48653d9bb9750e4ecca |
| publicationDate | 2005-07-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | RU-2256460-C2 |
| titleOfInvention | Method for treating inspecific bronchopneumonia in calves |
| abstract | FIELD: veterinary science. n SUBSTANCE: one should apply intrapleural novocaine-antibiotic blockade in combination with intramuscular injection of 10%-erancond-B solution at the dosage of 3.0 -3.5 mg/kg body weight for the first 4-5 d of therapy. Calves should be daily given a tincture out of coltsfoot leaves prepared at the ratio of 1 portion of grass per 10 portions of water, at 90 - 110 ml/calf thrice daily. Intake of 0.5 - 0.6 g ascorbic acid should last for 5-7 d. The method provides activation of immune systems, T-system, phagocytic and interferonogenic ones, in particular. n EFFECT: higher efficiency of therapy. n 1 ex, 4 tbl |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2774577-C1 |
| priorityDate | 2003-09-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 70.